3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Glioblastoma
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Interventions
Bevacizumab
12
olaparib
11
Paclitaxel
11
Carboplatin
11
liposomal doxorubicin
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
Taxes
5
Immunoglobulin G
5
Disulfides
5
mirvetuximab soravtansine
4
cediranib
4
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
Oxaliplatin
2
Doxorubicin
2
1-dodecylpyridoxal
2
vistusertib
1
tremelimumab
1
trastuzumab deruxtecan
1
sotorasib
1
sarilumab
1
palbociclib
1
niraparib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Leukapheresis
×
30 days
×
Clear all
No trials found.